A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Clinical trial NCT05444322 · UNKNOWN

Trial details

NCT number: NCT05444322
Sponsor: He Huang
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Mantle Cell Lymphoma Diffuse Large B-cell Lymphoma Follicular Lymphoma

Start date: 2022-07-05
Primary completion: 2024-07-10
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.